Ebola Viruses
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine (NCT02374385) | Dalhousie University | 2014-11-01 |
| Safety and Immunogenicity of Prime-Boost Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-002) (NCT02280408) | Merck Sharp & Dohme LLC | 2014-10-07 |
Track Ebola Viruses automatically
Every clearance here is in the API, with alerts when new ones post.